Business Context and Reporting Period
This Form 8-K Current Report from electroCore, Inc. (ECOR) is dated February 16, 2023. The filing addresses a delisting determination from the Nasdaq Stock Market LLC due to the Company's failure to maintain a minimum bid price of $1.00 per share for 10 consecutive trading days.
Key Financial Metrics
This filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate governance and listing status matters.
Material Changes and Events
- Delisting Notice: On December 20, 2022, the Company received a delisting determination letter from Nasdaq for non-compliance with the Bid Price Rule.
- Appeal and Hearing: The Company appealed the decision, and a hearing was held before the Nasdaq Hearings Panel on February 2, 2023.
- Reverse Stock Split: On February 13, 2023, stockholders approved a reverse stock split, which was implemented effective February 15, 2023, to increase the share price and regain compliance.
- Compliance Extension: On February 16, 2023, the Panel granted an extension for the Company to regain compliance with the Bid Price Rule until March 13, 2023.
Outlook, Risks, and Management Commentary
The Nasdaq Hearings Panel noted that, given the completion of the reverse stock split, the Company was likely to regain compliance by March 1, 2023. However, the Panel emphasized that there can be no assurance the Common Stock will timely regain compliance. The decision is subject to continued compliance with listing requirements and may be reviewed by the Nasdaq Listing and Hearing Review Council within 45 days. The filing includes standard forward-looking statement disclaimers regarding potential risks and uncertainties.
Investor Verification Checklist
- Verify the current trading price of ECOR to confirm if it has sustained the $1.00 minimum bid price following the reverse stock split.
- Monitor the Company's status regarding the March 13, 2023, compliance deadline set by the Nasdaq Hearings Panel.
- Review the Company's most recent Form 10-K for detailed risk factors and financial health, as this 8-K contains no financial metrics.
- Check for any subsequent filings regarding the potential review by the Nasdaq Listing and Hearing Review Council.